http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2739491-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcfea7bbbc4a634bc37ca8e1feae7cf2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
filingDate 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1e03d98bb63bc52fece76768e41f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1349840e65eff60a32258b31a1734434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d4b896a15cdaba4f8fce55cde08e878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf90757501f12851ee5c5dfdaf7f8ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8db6162d58f2550cddf8b701c9515382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efca1b3640fb7932d6255c14be0ae05b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15989ad981130224d916db5dc0351c80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_899d02a4d8dfb2fa2c0569d233825af3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f20bcb9b651abe4604350f89b5128918
publicationDate 2020-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2739491-C1
titleOfInvention Agent for preventing and treating asthenozoospermia and teratozoospermia
abstract FIELD: medicine; pharmaceuticals.SUBSTANCE: invention refers to medicine and pharmaceutics and can be used for prevention and treatment of asthenozoospermia and teratozoospermia. For this purpose, it is proposed to apply Verva fir extract in an effective dose once a day daily for 5 days before and 5 days after cytostatic exposure as an agent for prevention and treatment of asthenozoospermia and teratozoospermia.EFFECT: invention provides higher sperm cell mobility and reduced number of pathological forms in asthenozoospermia and teratozoospermia.1 cl, 1 ex, 2 dwg
priorityDate 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2634384-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2684673-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2318529-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID303185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284537
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID201163
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID137693
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID137693
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480897
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID216805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID496819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870

Total number of triples: 36.